GBP5 and psoriasis: Our results suggest that the high expression of GZBM, GBP5 and FOXP3 in CD8+ T cells drives the pathogenesis of psoriasis, therefore, inhibiting the expression of GZBM, GBP5 and FOXP3 is expected to be a new strategy to alleviate the progression of psoriasis.